Skip to main content
SpringerLink
Log in

ASO Author Reflections: Common, Proliferative, and Inflammatory Subtypes of Intrahepatic Cholangiocarcinoma

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tsilimigras DI, Hyer JM, Paredes AZ, et al. A novel classification of intrahepatic cholangiocarcinoma phenotypes using machine learning techniques: an international multi-institutional analysis. Ann Surg Oncol. 2020;27(13):5224–32.

    Article  Google Scholar 

  2. Czauderna C, Kirstein MM, Tews HC, et al. Molecular subtypes and precision oncology in intrahepatic cholangiocarcinoma. J Clin Med. 2021;10(13):2803.

    Article  CAS  Google Scholar 

  3. Job S, Rapoud D, Dos Santos A, et al. Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma. Hepatology. 2020;72(3):965–81.

    Article  CAS  Google Scholar 

  4. Alaimo L, Zorays M, Endo Y, et al. Long-term recurrence-free and overall survival differ based on Common, Proliferative, and Inflammatory subtypes after resection of intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12795-4.

    Article  Google Scholar 

  5. Guo X, Shen W. Latest evidence on immunotherapy for cholangiocarcinoma. Oncol Lett. 2020;20(6):381.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, Oncology, Health Services Management and Policy, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University, Wexner Medical Center, Columbus, OH, USA

    Laura Alaimo MD, Zorays Moazzam MD & Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.)

  2. James Comprehensive Cancer Center, Columbus, OH, USA

    Laura Alaimo MD, Zorays Moazzam MD & Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.)

  3. Department of Surgery, University of Verona, Verona, Italy

    Laura Alaimo MD

Authors
  1. Laura Alaimo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zorays Moazzam MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.).

Ethics declarations

Disclosures

Laura Alaimo, Zorays Moazzam, and Timothy M. Pawlik declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alaimo, L., Moazzam, Z. & Pawlik, T.M. ASO Author Reflections: Common, Proliferative, and Inflammatory Subtypes of Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 30, 1404–1405 (2023). https://doi.org/10.1245/s10434-022-12805-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12805-5

Search

Navigation